THESEUS PHARMACEUTICALS INC - COM (THRX)

CUSIP: 88369M101

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COM
Total 13F shares
35,194,795
Share change
-4,667,878
Total reported value
$94,671,533
Price per share
$2.69
Number of holders
62
Value change
-$58,405,910
Number of buys
29
Number of sells
35

Quarterly Holders Quick Answers

What is CUSIP 88369M101?
CUSIP 88369M101 identifies THRX - THESEUS PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THESEUS PHARMACEUTICALS INC - COM (THRX) as of Q3 2023

As of 30 Sep 2023, THESEUS PHARMACEUTICALS INC - COM (THRX) was held by 62 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,194,795 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Foresite Capital Management V, LLC, Frazier Life Sciences Management, L.P., MILLENNIUM MANAGEMENT LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Omega Fund Management, LLC, Lynx1 Capital Management LP, and Nextech Invest Ltd.. This page lists 62 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.